Ketamine for Depression-Knowns, Unknowns, Possibilities, Barriers, and Opportunities

被引：7
作者：
Andrade, Chittaranjan [1 ,2 ]
机构：
[1] Natl Inst Mental Hlth & Neurosci, Dept Clin Psychopharmacol & Neurotoxicol, Bangalore, India
[2] Natl Inst Mental Hlth & Neurosci, Dept Clin Psychopharmacol & Neurotoxicol, Hosur Rd, Bangalore 560029, Karnataka, India
来源：
JAMA PSYCHIATRY | 2023年 / 80卷 / 12期
关键词：
INTRAVENOUS KETAMINE;
D O I：
10.1001/jamapsychiatry.2023.3982
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
This Viewpoint discusses ketamine and its new and experimentally investigated on- and off-label indications that span different medical disciplines.
引用
收藏
页码：1189 / 1190
页数：2
相关论文
共 9 条
  • [1] Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
    Anand, A.
    Mathew, S. J.
    Sanacora, G.
    Murrough, J. W.
    Goes, F. S.
    Altinay, M.
    Aloysi, A. S.
    Asghar-Ali, A. A.
    Barnett, B. S.
    Chang, L. C.
    Collins, K. A.
    Costi, S.
    Iqbal, S.
    Jha, M. K.
    Krishnan, K.
    Malone, D. A.
    Nikayin, S.
    Nissen, S. E.
    Ostroff, R. B.
    Reti, I. M.
    Wilkinson, S. T.
    Wolski, K.
    Hu, B.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (25) : 2315 - 2325
  • [2] Oral Ketamine for Depression, 2: Practical Considerations
    Andrade, Chittaranjan
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2019, 80 (02)
  • [3] Racemic Ketamine as an Alternative to Electroconvulsive Therapy for Unipolar Depression: A Randomized, Open-Label, Non-Inferiority Trial (KetECT)
    Ekstrand, Joakim
    Fattah, Christian
    Persson, Marcus
    Cheng, Tony
    Nordanskog, Pia
    Akeson, Jonas
    Tingstrom, Anders
    Lindstrom, Mats B.
    Nordenskjold, Axel
    Rad, Pouya Movahed
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2022, 25 (05) : 339 - 349
  • [4] The efficacy of oral ketamine in severely depressed patients at high risk of suicide
    Kaur, Saswinder
    Parmar, Chirag
    Gaur, Vikas
    Chauhan, Ajay
    Andrade, Chittaranjan
    [J]. ASIAN JOURNAL OF PSYCHIATRY, 2023, 86
  • [5] A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009-January 2019
    Marcantoni, Walter S.
    Akoumba, Bertine Sandra
    Wassef, Maggy
    Mayrand, Julie
    Lai, Hinatea
    Richard-Devantoy, Stephane
    Beauchamp, Sylvie
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2020, 277 : 831 - 841
  • [6] Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode A Systematic Review and Meta-analysis
    Rhee, Taeho Greg
    Shim, Sung Ryul
    Forester, Brent P.
    Nierenberg, Andrew A.
    McIntyre, Roger S.
    Papakostas, George, I
    Krystal, John H.
    Sanacora, Gerard
    Wilkinson, Samuel T.
    [J]. JAMA PSYCHIATRY, 2022, 79 (12) : 1162 - 1172
  • [7] Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review
    Walsh, Zach
    Mollaahmetoglu, Ozden Merve
    Rootman, Joseph
    Golsof, Shannon
    Keeler, Johanna
    Marsh, Beth
    Nutt, David J.
    Morgan, Celia J. A.
    [J]. BJPSYCH OPEN, 2021, 8 (01):
  • [8] Safety and Tolerability of the Acute Ketamine Treatment in Treatment-Resistant Depression: Focus on Comorbidities Interplay with Dissociation and Psychomimetic Symptoms
    Wlodarczyk, Adam
    Dywel, Alicja
    Cubala, Wieslaw Jerzy
    [J]. PHARMACEUTICALS, 2023, 16 (02)
  • [9] The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis
    Xiong, Jiaqi
    Lipsitz, Orly
    Chen-Li, David
    Rosenblat, Joshua D.
    Rodrigues, Nelson B.
    Carvalho, Isabelle
    Lui, Leanna M. W.
    Gill, Hartej
    Narsi, Flora
    Mansur, Rodrigo B.
    Lee, Yena
    McIntyre, Roger S.
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2021, 134 : 57 - 68
1